Neurotrophic mediators and corneal wound healing

Ocular Surface

Volumn 3, Issue 4, 2005, Pages 194-202

  Nishida, Teruo ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cornea; Epithelial defect; Epithelial migration; Fibronectin; Insulin like growth factor 1; Integrin; Nerve growth factor; Substance P; Wound healing

Indexed keywords

AMIDE; BASIC FIBROBLAST GROWTH FACTOR; CAPSAICIN; EYE DROPS; NERVE GROWTH FACTOR; NEUROTRANSMITTER; NONSTEROID ANTIINFLAMMATORY AGENT; POLYPEPTIDE; SOMATOMEDIN C; SUBSTANCE P; TETRAPEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ARTICLE; CELL MIGRATION; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA INJURY; DRUG POTENTIATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KERATOPATHY; NERVE FUNCTION; NONHUMAN; TRIGEMINAL NERVE; WOUND HEALING;

EID: 27844500226     PISSN: 15420124     EISSN: 15420124     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70206-9     Document Type: Article

References (91)

1. Tervo T, Palkama A. Innervation of the rabbit cornea. A histochemical and electron-microscopic study. Acta Anat (Basel) 1978;102:164-75
2. Marfurt CF, Kingsley RE, Echtenkamp SE. Sensory and sympathetic innervation of the mammalian cornea. A retrograde tracing study. Invest Ophthalmol Vis Sci 1989;30:461-72
3. Muller LJ, Pels L, Vrensen GF. Ultrastructural organization of human corneal nerves. Invest Ophthalmol Vis Sci 1996;37:476-88
4. Muller LJ, Vrensen GF, Pels L, et al. Architecture of human corneal nerves. Invest Ophthalmol Vis Sci 1997;38:985-94
5. Marfurt CF, Murphy CJ, Florczak JL. Morphology and neurochemistry of canine corneal innervation. Invest Ophthalmol Vis Sci 2001;42:2242-51
6. Muller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76:521-42
7. Acosta MC, Tan ME, Belmonte C, Gallar J. Sensations evoked by selective mechanical, chemical, and thermal stimulation of the conjunctiva and cornea. Invest Ophthalmol Vis Sci 2001;42:2063-7
8. Belmonte C, Acosta MC, Gallar J. Neural basis of sensation in intact and injured corneas. Exp Eye Res 2004;78:513-25
9. Belmonte C, Adolfo Aracil A, Acosta MC,. Nerves and sensations from the eye surface. Ocular Surface 2004;2:248-53
10. Magendie PA. De l'influence de la cinquieme paire de nerfs sur la nutrition et les fonctions de l'oeil. J Physiol (Paris) 1824;4:176-7
11. Mishima S. The effects of the denervation and the stimulation of the sympathetic and the trigeminal nerve on the mitotic rate of the corneal epithelium in the rabbit. Jpn J Ophthalmol 1957;1:65-73
12. Lim CH. Innervation of the cornea of monkeys and the effects of denervation. Br J Physiol Opt 1976;31:38-42
13. Beuerman RW, Schimmelpfennig B. Sensory denervation of the rabbit cornea affects epithelial properties. Exp Neurol 1980;69:196-201
14. Klyce SD, Beuerman RW, Crosson CE. Alteration of corneal epithelial ion transport by sympathectomy. Invest Ophthalmol Vis Sci 1985;26:434-42
15. Nishida T, Tanaka T. Extracellular matrix and growth factors in corneal wound healing. Curr Opin Ophthalmol 1996;7:2-11
16. Murakami J, Nishida T, Otori T. Coordinated appearance of beta 1 integrins and fibronectin during corneal wound healing. J Lab Clin Med 1992;120:86-93
17. Nishida T, Nakagawa S, Awata T, et al. Fibronectin promotes epithelial migration of cultured rabbit cornea in situ. J Cell. Biol 1983;97:1653-7
18. Nishida T, Nakagawa S, Nishibayashi C, et al. Fibronectin enhancement of corneal epithelial wound healing of rabbits in vivo. Arch Ophthalmol 1984;102:455-6
19. Nakamura M, Sato N, Chikama T, et al. Fibronectin facilitates corneal epithelial wound healing in diabetic rats. Exp Eye Res 1997;64:355-9
20. Nishida T, Nakagawa S, Awata T, et al. Rapid preparation of purified autologous fibronectin eyedrops from patient's plasma. Jpn J Ophthalmol. 1982;26:416-424.
21. Nishida T, Nakagawa S, Awata T, et al. Fibronectin eyedrops for traumatic recurrent corneal lesion. Lancet 1983;2:521-2
22. Nishida T, Nakagawa S, Manabe R. Clinical evaluation of fibronectin eyedrops on epithelial disorders after herpetic keratitis. Ophthalmology 1985;92:213-6
23. Lambiase A, Rama P, Aloe L, Bonini S. Management of neurotrophic keratopathy. Curr Opin Ophthalmol 1999;10:270-6
24. Davis EA, Dohlman CH. Neurotrophic keratitis. Int Ophthalmol Clin 2001;41:1-11
25. Bonini S, Rama P, Olzi D, Lambiase A. Neurotrophic keratitis. Eye 2003;17:989-95
26. Goins KM. New insights into the diagnosis and treatment of neurotrophic keratopathy. Ocular Surface 2005;3:96-110
27. Lawrenson JG. Corneal sensitivity in health and disease. Ophthalmic Physiol Opt 1997;17 Suppl 1:S17-22
28. Pushker N, Dada T, Vajpayee RB, et al. Neurotrophic keratopathy. CLAO J 2001;27:100-7
29. Peet MM, Schneider RC. Trigeminal neuralgia: A review of six hundred and eighty-nine cases with a follow-up study on sixtyfive per cent of the group. J Neurosurg 1952;9:367-77
30. Davies MS. Corneal anaesthesia after alcohol injection of the trigeminal sen sory root. Examination of 100 anaesthetic corneae. Br J Ophthalmol 1970;54:577-86
31. Richter A, Slowik C, Somodi S, et al. Corneal reinnervation following penetrating keratoplasty-correlation of esthesiometry and confocal microscopy. Ger J Ophthalmol 1996;5:513-17
32. Ruben M, Colebrook E. Keratoplasty sensitivity. Br J Ophthalmol 1979;63:265-7
33. Heinz P, Bodanowitz S, Wiegand W, Kroll P. In vivo observation of corneal nerve regeneration after photorefractive keratectomy with a confocal videomicroscope. Ger J Ophthalmol 1996;5:373-7
34. Latvala T, Barraquer-Coll C, Tervo K, Tervo T. Corneal wound healing and nerve morphology after excimer laser in situ keratomileusis in human eyes. J Refract Surg 1996;12:677-83
35. Matsui H, Kumano Y, Zushi I, et al. Corneal sensation after correction of myopia by photorefractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg 2001;27:370-3
36. Wilson SE. Laser in situ keratomileusis-induced (presumed) neurotrophic epitheliopathy. Ophthalmology 2001;108:1082-7
37. Wilson SE, Ambrosio R. Laser in situ keratomileusis-induced neurotrophic epitheliopathy. Am J Ophthalmol 2001;132:405-6
38. Lee BH, McLaren JW, Erie JC, et al. Reinnervation in the cornea after LASIK. Invest Ophthalmol Vis Sci 2002;43:3660-4
39. Kumano Y, Matsui H, Zushi I, et al. Recovery of corneal sensation after myopic correction by laser in situ keratomileusis with a nasal or superior hinge. J Cataract Refract Surg 2003;29:757-61
40. Savini G, Barboni P, Zanini M, Tseng SC. Ocular surface changes in laser in situ keratomileusis-induced neurotrophic epitheliopathy. J Refract Surg 2004;20:803-9
41. Park TS, Park JH, Back HS. Can diabetic neuropathy be prevented? Diabetes Res Clin Pract 2004;66 Suppl 1:S53-56
42. Schwartz DE. Corneal sensitivity in diabetics. Arch Ophthalmol 1974;91:174-8
43. Hyndiuk RA, Kazarian EL, Schultz RO, Seideman S. Neurotrophic corneal ulcers in diabetes mellitus. Arch Ophthalmol 1977;95:2193-6
44. Schultz RO, Van Horn DL, Peters MA, et al. Diabetic keratopathy. Trans Am Oplithalmol Soc 1981;79:180-99
45. Schultz RO, Peters MA, Sobocinski K, et al. Diabetic keratopathy as a manifestation of peripheral neuropathy. Am J Ophthalmol 1983;96:368-71
46. Kallinikos P, Berhanu M, O'Donnell C, et al. Corneal nerve tortuosity in diabetic patients with neuropathy. Invest Ophthalmol Vis Sci 2004;45:418-22
47. Rogell GD. Corneal hypesthesia and retinopathy in diabetes mellitus. Ophthalmology 1980;87:229-33
48. Saito J, Enoki M, Hara M, et al. Correlation of corneal sensation, but not of basal or reflex tear secretion, with the stage of diabetic retinopathy. Cornea 2003;22:15-8
49. Elsas T, Edvinsson L, Sundler F, Uddman R. Neuronal pathways to the rat conjunctiva revealed by retrograde tracing and immmocytochemistry. Exp Eye Res 1994;58:117-26
50. Miller A, Costa M, Furness JB, Chubb IW. Substance P immunoreactive sensory nerves supply the rat iris and cornea. Neurosci Lett 1981;23:243-9
51. Tervo K, Tervo T, Eranko L, Eranko O. Substance P immunoreactive nerves in the rodent cornea. Neurosci Lett 1981;25:95-7
52. Shimizu Y. Localization of neuropeptides in the cornea and uvea of the rat: an immunohistochemical study. Cell Mol Biol 1982;28:103-10
53. Stone RA, Laties AM, Brecha NC. Substance P-like immunoreactive nerves in the anterior segment of the rabbit, cat and monkey eye. Neuroscienc. 1982;7:2459-68
54. Tervo K, Tervo T, Eranko L, et al. Substance P-immunoreactive nerves in the human cornea and iris. Invest Ophthalmol Vis Sci 1982;23:671-4
55. Sasaoka A, Ishimoto I, Kuwayama Y, et al. Overall distribution of substance P nerves in the rat cornea and their three-dimensional profiles. Invest Ophthalmol Vis Sci 1984;25:351-6
56. Stone RA, Kuwayama Y. Substance P-like immunoreactive nerves in the human eye. Arch Ophthalmol 1985;103:1207-11
57. Selbach JM, Buschnack SH, Steuhl KP, et al. Substance P and opioid peptidergic innervation of the anterior eye segment of the rat: an immunohistochemical study. J Anat 2005;206:237-42
58. Yamada M, Ogata M, Kawai M, et al. Substance P and its metabolites in normal human tears. Invest Ophthalmol Vis Sci 2002;43:2622-5
59. Yamada M, Ogata M, Kawai M, et al. Substance P in human tears. Cornea 2003;22:S48-54
60. Yamada M, Ogata M, Kawai M, Mashima Y. Decreased substance P concentrations in tears from patients with corneal hypesthesia. Am J Ophthalmol 2000;129:671-2
61. Yamada M, Ogata M, Kawai M, et al. Topical diclofenac sodium decreases the substance P content of tears. Arch Ophthalmol 2002;120:51-4
62. Araki-Sasaki & Aizawa S, Hiramoto M, et al. Substance P-in-duced cadherin expression and its signal transduction in a cloned human corneal epithelial cell line. J Cell Physiol 2000;182:189-95
63. Tran MT, Lausch RN, Oakes JE. Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells. Invest Oplithalmol Vis Sci 2000;41:3871-7
64. Watanabe M, Nakayasu & Iwatsu M, Kanai A. Endogenous substance P in corneal epithelial cells and keratocytes. Jpn J Ophthalmol 2002;46:616-20
65. Garcia-Hirschfeld J, Lopez-Briones LG, Belmonte C. Neurotrophic influences on corneal epithelial cells. Exp Eye Res 1994;59:597-605
66. Reid TW, Murphy CJ, Iwahashi CK, et al. Stimulation of epithelial cell growth by the neuropeptide substance P. J Cell Biochem 1993;52:476-85
67. Nishida T, Nakamura M, Ofuji K, et al. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol 1996;169:159-66
68. Nakamura M, Nishida T, Ofuji K, & et al. Synergistic effect of substance P with epidermal growth factor on epithelial migration in rabbit cornea. Exp Eye Res 1997;65:321-9
69. Nakamura M, Ofuji K, Chikama T, Nishida T. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1. Br J Pharmacol 1997;120:547-52
70. Ofuji K, Nakamura M, Nishida T. Signaling regulation for synergistic effects of substance P and insulin-like growth factor-1 or epidermal growth factor on corneal epithelial migration. Jpn J Ophthalmol 2000;44:1-8
71. Nakamura M, Chikama T, Nishida T. Up-regulation of integrin alpha 5 expression by combination of substance P and insulin-like growth factor-1 in rabbit comeal epithelial cells. Biochem Biophys Res Commun 1998;246:777-82
72. Nakamura M, Nagano T, Chikama T, Nishida T. Up-regulation of phosphorylation of focal adhesion kinase and paxillin by combination of substance P and IGF-1 in SV-40 transformed human corneal epithelial cells. Biochem Biophys Res Commun 1998;242:16-20
73. Nakamura M, Chikama TL Nishida T. Characterization of insulin-like growth factor-1 receptors in rabbit corneal epithelial cells. Exp Eye Res 2000;70:199-204
74. Nakamura M, Ofuji K, Chikama T, Nishida T. Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo. Curr Eye Res 1997;16:275-8
75. Nagano T, Nakamura M, Nakata K, et al. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. Invest Ophthalmol Vis Sci 2003;44:3810-5
76. Nakamura M, Kawahara M, Nakata K, Nishida T. Restoration of corneal epithelial barrier function and wound healing by substance P and IGF-1 in rats with capsaicin-induced neurotrophic keratopathy. Invest Ophthalmol Vis Sci 2003;44:2937-40
77. Nakamura M, Chikama T, Nishida T. Synergistic effect with Phe-Gly-Leu-Met-NH2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea. Br J Pharmacol 1999;127:489-97
78. Chikama T, Nakamura M, Nishida T. Up-regulation of integrin alpha5 by a C-terminus four-amino-acid sequence of substance P (phenylalanine-glycine-leucine-methionine- amide) synergistically with insulin-like growth factor-1 in SV-40 transformed human corneal epithelial cells. Biochem Biophys Res Commun 1999;255:692-7
79. Nakamura M, Kawahara M, Morishige N, et al. Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1. Diabetologia 2003;46:839-42
80. Yamada N, Yanai R, Nakamura M, et al. Role of the C domain of IGFs in synergistic promotion, with a substance P-derived peptide, of rabbit corneal epithelial wound healing. Invest Ophthalmol Vis Sci 2004;45:1125-31
81. Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. Arch Ophthalmol 1997;115:926-7
82. Chikama T, Fukuda K, Morishige N, Nishida T. Treatment of neurotrophic keratopathy with substance-P-derived puptide (FGLM) and insulin-like growth factor I. Lancet 1998;351:1783-4
83. Morishige N, Komatsubara T, Chikama T, Nishida T. Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy. Lancet 1999;354:1613-4
84. Brown SM, Khanani AM, Stetson CL, Reid TW. Vesicular eruption in a child with trigeminal nerve palsy during topical therapy with substance p and insulinlike growth factor I for neurotrophic keratitis. Arch Ophthalmol 2004;122:1722-3
85. Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998;338:1174-80
86. Lambiase A, Manni L, Bonini S, et al. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci 2000;41:1063-9
87. Bonini S, Lambiase A, Rama P, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 2000;107:1347-51; discussion 1351-2
88. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy, Ophthalmology. 2004;111:1115-20
89. Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol 2001;85:1455-63
90. Tseng SC. Amniotic membrane transplantation for persistent corneal epithelial defect Br J Ophthalmol 2001;85:1400-1401.
91. Yamada N, Yanai R, Inui M, Nishida T. Sensitizing effect of substance P on corneal epithelial migration induced by IGF-1, fibronectin, or interleukin-6. Invest Ophthalmol Vis Sci 2005;46:833-9